4 Amendments of Krzysztof HETMAN related to 2016/2057(INI)
Amendment 213 #
Motion for a resolution
Paragraph 4 a (new)
Paragraph 4 a (new)
4a. Underlines the role of European research projects and SMEs in improving the access to medicines at the European level, highlights the role of Horizon 2020 programme in this respect.
Amendment 433 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on the Commission to promote open data in private research, especially where public funding is involved, and to establish conditions such as affordable pricing and non-exclusivity, or co- ownership of IP for projects funded by EU public grants such as Horizon 2020;
Amendment 501 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Calls on the Commission to propose legislation on a European system for health technology assessment as soon as possible, and to assess added-value medicines compared with the best available alternative; also calls on the Commission to harmonise pricing procedure and reimbursement criteria to take into account the level of innovation and the social and economic cost-benefit analysis, and to put in place a European classification on the added value level of medicines;
Amendment 547 #
Motion for a resolution
Paragraph 29
Paragraph 29
29. Calls on the Commission and the Council to explore in justified cases new measures to control prices, such as horizontal scanning and coordinating joint procurements;